Zhang, Y., Fu, Y., Tang, X., Wang, J., Chen, J., Chen, M. (2026). Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) plus tislelizumab (Tisle) combined with adjuvant tisle as a perioperative therapy for hepatocellular carcinoma (HCC) at high-risk of recurrence: A single-arm, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16284